Sweden· SE-20150325000088
Sitagliptin Teva 25 mg Filmdragerad tablett
A sitagliptin product containing sitagliptin malate, registered in Sweden by Teva Sweden AB. The same ATC class is registered in 19 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Sitagliptin is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 11 of them publish a price we can compare per daily dose
Sitagliptin · ATC A10BH01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sitagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sitagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.47
- IT Italy$1.78
- ES Spain$1.08
- FR France$0.65
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Sitagliptin Malate
- Manufacturer
- Teva Sweden AB
- Country
- Sweden (SE)
- ATC code
- A10BH01
- ATC class
- Sitagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20150325000088
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for sitagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sitagliptin · interactions on record
341 records
- 3 severe
- 292 moderate
- 44 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sitagliptin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandSitagliptin ratiopharmratiopharm GmbH
- CzechiaSITAGLIPTIN TEVATeva Pharmaceuticals CR, s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Sitagliptin Ratiopharm
- Germany · Sitagliptin Ratiopharm
- Finland · Sitagliptin Ratiopharm
- France · Sitagliptine Teva
- United Kingdom (Northern Ireland) · Sitagliptin Teva
- Croatia · Sitagliptin Teva
- Italy · Sitagliptin Teva
- Lithuania · Sitagliptin Teva
- Latvia · Sitagliptin Teva
- Netherlands · Sitagliptin Teva
- Poland · Sitagliptin Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3f35967c-42f8-46db-983d-303c873f0e8b GET /v1/drugs/3f35967c-42f8-46db-983d-303c873f0e8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20150325000088",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150325000088",
"product_doc_link": "https://docetp.mpa.se/LMF/Sitagliptin%20Teva%20film-coated%20tablet%20SmPC_09001bee81f08ce8.pdf"
}See everything about sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.